ended of 30 June 2017 Attention: Directors and Manager The Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the six

ended of 30 June 2017 (Revised) Attention: Directors and Manager The Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results

higher revenue per visit of non-social security category but also from the efficient cost control of medicine and supplies as well as staff. Administrative Expenses Administrative expenses decreased by 13

IPD which generated highest margin comparing to other categories. Moreover, the efficient cost management such as medicine & medical supplies as well as the benefit from economy of scale in term of

Laboratories Co., Ltd. is a listed company established in the year 1971. The manufacture and distribution of conventional medicine. Office and Factory are located at No.47 Soi Boonchana, Sukhumvit 59, Klong Ton

investment of ward renovation and medical equipment while revenue contracted. However, percent of medicine & supplies and doctor’s fee cost to revenue decreased on back of fewer number of SW patients visit

Attn : The Directors and The MAI Manager Ref: Dimet AC 1902/001 February 12, 2019 Attention: The Directors and The MAI Manager The Stock Exchange of Thailand Subject: Report on Q.2’s performance

Microsoft Word - วิเคราะห์ Q362-ENG 14 November 2019 Subject :Management discussion and analysis of financial statement for three-month period ended 30 September 2019 Attention :Director and Manager

Attn : The Directors and The MAI Manager Ref: Dimet AC 0817/1 August 30, 2017 Attention: The Directors and The MAI Manager The Stock Exchange of Thailand Subject: Year End result and clarification of

Attn : The Directors and The MAI Manager Ref: Dimet ACC 1711/001 November 9, 2017 Attention: The Directors and The MAI Manager The Stock Exchange of Thailand Subject: Report on Q1’s performance Dear